Using 3D Echocardiography to Improve Device Closure for Atrial Septal Defect

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of three-dimensional transesophageal echocardiography in determining the optimal device size for closing atrial septal defects (ASD). The investigators aim to predict the correct device size and validate a previously developed formula before performing the device closure procedure. By utilizing advanced imaging techniques, the study seeks to enhance the accuracy of ASD closures and improve patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 year-old
* Susceptible indication for atrial septal defect closure
* Potential candidate for device closure

Exclusion Criteria:

* Poor candidate for device closure: multiple ASDs, ect
* Other heart disease requiring open heart surgery

Where it's running

• Asan Medical Center
  Seoul, South Korea Recruiting

Study contacts

• Principal investigator: Jong-Min Song, MD PhD — Asan Medical Center
• Study coordinator: Jong-Min Song, MD,PhD
• Email: jmsong@amc.seoul.kr
• Phone: +82-2-3010-3168

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Follow-up on the Lifetech Cera™ ASD Occluder for heart defect treatment

  This study is looking to see how well the Lifetech Cera™ ASD Occluder works and if it’s safe for people who have had it implanted to fix a heart defect.

  Recruiting Lifetech Scientific (Shenzhen) Co., Ltd. · Myszków and 5 other locations · NCT06849635

• Investigating cerebral microembolization in patients with PFO closure

  This study is trying to see if patients with a heart condition called PFO who undergo a closure procedure experience tiny blood clots in the brain and how these might relate to existing clots in the heart.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT06347276

• High-dose vs standard-dose flu vaccine in adults with blood cancers on B-cell-depleting therapy

  This study tests whether a high-dose flu shot evokes a stronger immune response than a standard-dose shot in adults with hematologic cancers who recently had B-cell-depleting therapy.

  Recruiting Phase 2 Asan Medical Center · Seoul · NCT07926217

• Videoconference Brief Cognitive Behavioral Therapy for mood disorders at high suicide risk

  This study tests a short online CBT program to help people with mood disorders who are at high risk of suicide, and compares inflammatory biomarkers between groups.

  Recruiting Asan Medical Center · Seoul · NCT07857291

• AI-based prediction of five major diseases using integrated health data

  Researchers are testing an AI model to see if they can predict the onset of five major diseases in adults 30–65 by combining medical records with biospecimens and lifestyle data.

  Recruiting Asan Medical Center · Seoul, Seoul Special City · NCT07595718

• Noninferiority test of a sirolimus-ascorbic acid stent vs everolimus stent in heart disease patients

  This study tests whether a sirolimus-ascorbic acid eluting stent works as well as the standard everolimus-eluting stent for people with coronary artery disease undergoing PCI.

  Recruiting Asan Medical Center · Seoul · NCT07566091

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.